Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 7
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Fypryst Combo 268mg/241,2mg - V/DCP/14/0012 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0012-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0012-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0012-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0012-04 10 Polipropilēna pipete, 1 deva -
Aurizon - V/NRP/03/1574 Vetoquinol S.A., Francija QS02CA06 dogs Vairāk

Medicinal product information

Pharmaceutical form: ear drops, suspension
International name (active substance): Marbofloxacin, Clotrimasolum, Dexamethasone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1574-01 1 Pudelīte, 10 ml -
V/NRP/03/1574-02 1 Pudelīte, 20 ml -
V/NRP/03/1574-03 1 Pudelīte, 30 ml -
Pergocoat 0.25 mg V/DCP/25/0071 Alfasan Nederland BV, Nīderlande QN04BC02 horses Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Pergolide mesylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 20-Nov-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0071-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-02 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-03 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-04 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-05 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-06 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-07 16 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-08 24 PVH/PE/PVDH-Al blisteris, 10 tablete -
Doxycare 40 mg V/DCP/19/0069 Ecuphar NV, Beļģija QJ01AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycycline (as Doxycycline hyclate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0069-01 40 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-02 40 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-03 40 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-04 40 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-05 40 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-06 40 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-07 40 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-08 40 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-09 40 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-10 40 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-11 40 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
Doxycare 200 mg V/DCP/19/0070 Ecuphar NV, Beļģija QJ01AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycycline (as Doxycycline hyclate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0070-01 200 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-02 200 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-03 200 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-04 200 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-05 200 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-06 200 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-07 200 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-08 200 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-09 200 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-10 200 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-11 200 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimocard 2.5 mg V/MRP/15/0061 Eurovet Animal Health B.V., Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: flavoured tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dales Pharmaceuticals Ltd., Lielbritānija;Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 260122LI (26-Jan-2022)
Labelling text: [PDF] 280717M (31-Jul-2017)
Summary of product characteristics: [PDF] 280717ZA (31-Jul-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0061-01 2,5 mg 2 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-02 2,5 mg 5 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-03 2,5 mg 10 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-04 2,5 mg 25 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-05 2,5 mg 2 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-06 2,5 mg 5 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-07 2,5 mg 10 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-08 2,5 mg 25 Al/Al blisteris, 10 tablete -
Vetmulin 125 mg/ml V/DCP/19/0001 Huvepharma NV, Beļģija QJ01XQ01 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Tiamulin hydrogen fumarate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet Joint Stock Company., Bulgārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0001-01 1 ABPE pudele, 1 l -
V/DCP/19/0001-02 1 ABPE pudele, 5 l -
Noromectin Duo - V/DCP/13/0034 Norbrook Laboratories (Ireland) Limited, Īrija QP54AA51 horses Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Ivermectin, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 31-Oct-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Summary of product characteristics: [PDF] Zāļu_informācija_ZA_M_LI (08-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0034-01 1 Pilnšļirce, 7,49 g -
V/DCP/13/0034-02 2 Pilnšļirce, 7,49 g -
V/DCP/13/0034-03 12 Pilnšļirce, 7,49 g -
V/DCP/13/0034-04 40 Pilnšļirce, 7,49 g -
V/DCP/13/0034-05 48 Pilnšļirce, 7,49 g -
V/DCP/13/0034-06 50 Pilnšļirce, 7,49 g -
Nobivac Rabies - V/NRP/93/0040 Intervet International B.V., Nīderlande QI07AA02 ferrets; cattle; sheep; goats; horses; dogs; cats; foxes Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus strain Pasteur RIV
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0040-01 10 Flakons, 1 deva -
V/NRP/93/0040-02 10 Flakons, 10 deva -
Octollar 1.25 g + 0.56 g - V/SRP/26/0008 Elanco GmbH, Vācija QP53AC55 dogs < 8 kg; cats Vairāk

Medicinal product information

Pharmaceutical form: medicated collar
International name (active substance): Imidacloprid, Flumethrin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 23-Feb-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/26/0008-01 1 Paciņa, 1 deva -
V/SRP/26/0008-02 2 Paciņa, 1 deva -
V/SRP/26/0008-03 12 Paciņa, 1 deva -
Octollar 4.50 g + 2.03 g - V/SRP/26/0009 Elanco GmbH, Vācija QP53AC55 dogs > 8 kg Vairāk

Medicinal product information

Pharmaceutical form: medicated collar
International name (active substance): Imidacloprid, Flumethrin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 23-Feb-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/26/0009-01 1 Paciņa, 1 deva -
V/SRP/26/0009-02 2 Paciņa, 1 deva -
V/SRP/26/0009-03 12 Paciņa, 1 deva -
Lozenord 5 mg/ml V/SRP/26/0011 Accord Healthcare B.V., Nīderlande QM01AC06 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fundacio Privada Dau, Spānija
Date of authorisation/renewal: 24-Feb-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/26/0011-01 1 Stikla flakons, 10 ml -
Ketamin 10% 100 mg/ml V/NRP/02/1507 Alivira Animal Health Limited;, Īrija QN01AX03 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release LABORATORIOS KARIZOO, S.A., Spānija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1507-01 100 mg/ml 10 Stikla flakons, 10 ml -
V/NRP/02/1507-02 100 mg/ml 10 Stikla flakons, 25 ml -
Apravet 552 IU/mg V/DCP/18/0045 Huvepharma NV, Beļģija QA07AA92 pigs; rabbits; calves; chickens Vairāk

Medicinal product information

Pharmaceutical form: Powder for use in drinking water/milk
International name (active substance): Apramycin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet Joint Stock Company., Bulgārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0045-01 1 ABPE pudele, 90,58 g -
V/DCP/18/0045-02 25 PE/AL/PP paciņa, 1,81 g -
V/DCP/18/0045-03 50 PE/AL/PP paciņa, 1,81 g -
V/DCP/18/0045-04 1 Maiss, 1811,6 g -
V/DCP/18/0045-05 1 PE/AL/PP paciņa, 1,81 g -
Enrocat flavour 25 mg/ml V/DCP/20/0016 Industrial Veterinaria, S.A., Spānija QJ01MA90 cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Enrofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija;aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0016-01 25 mg/ml 1 ABPE pudele, 8,5 ml -
DINOPROST Bioveta 5 mg/ml V/DCP/26/0012 Bioveta a.s., Čehija QG02AD01 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Dinoproston tromethamine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 03-Mar-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (03-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0012-01 1 Stikla flakons, 10 ml -
V/DCP/26/0012-02 1 Stikla flakons, 50 ml -
Ketiva 150 mg/ml V/DCP/26/0013 VetViva Richter GmbH , Austrija QM01AE03 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketoprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 03-Mar-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0013-01 1 Stikla flakons, 100 ml -
V/DCP/26/0013-02 10 Stikla flakons, 100 ml -
Novamune - V/DCP/18/0053 Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: concentrate and solvent for suspension for injection
International name (active substance): Live attenuated Infectious Bursal Disease virus, serotype 1, strain SYZA26
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jun-2025)
Summary of product characteristics: [PDF] Zāļu_informācija_ZA_M_LI (03-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0053-01 1 Stikla ampula (2ml), 500 deva -
V/DCP/18/0053-02 1 Stikla ampula (2ml), 1000 deva -
V/DCP/18/0053-03 1 Stikla ampula (5ml), 2000 deva -
V/DCP/18/0053-04 1 Stikla ampula (5ml), 500 deva -
V/DCP/18/0053-05 1 Stikla ampula (5ml), 1000 deva -
V/DCP/18/0053-06 1 Maisiņš, 200 ml -
V/DCP/18/0053-07 1 Maisiņš, 400 ml -
V/DCP/18/0053-08 1 Maisiņš, 800 ml -
V/DCP/18/0053-09 1 Maisiņš, 1000 ml -
V/DCP/18/0053-10 1 Maisiņš, 1200 ml -
V/DCP/18/0053-11 1 Maisiņš, 1600 ml -
Thiafeline 2.5 mg V/DCP/13/0025 Le Vet Beheer B.V., Nīderlande QH03BB02 cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Thiamazol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2019)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0025-01 2,5 mg 1 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-02 2,5 mg 2 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-03 2,5 mg 4 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-04 2,5 mg 5 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-05 2,5 mg 10 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
Synulox RTU - V/NRP/02/1476 Zoetis Belgium S.A., Beļģija QJ01CR02 cattle; pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 07-Dec-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1476-01 1 Flakons, 100 ml -
V/NRP/02/1476-02 1 Flakons, 40 ml -
V/NRP/02/1476-03 12 Flakons, 40 ml -
V/NRP/02/1476-04 6 Flakons, 100 ml [PDF] [PDF]

3082 records

© Food and veterinary service · 2026 Cookies policy